Quarterly report pursuant to Section 13 or 15(d)

EQUITY - Narrative (Details)

v3.23.3
EQUITY - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 23 Months Ended
Jun. 26, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2023
Sep. 30, 2023
Sep. 20, 2023
Feb. 27, 2023
Dec. 31, 2022
Jan. 31, 2022
Nov. 30, 2021
May 17, 2021
Schedule of Equity Method Investments [Line Items]                        
Common stock, shares authorized (in shares)   42,000,000     42,000,000 42,000,000     42,000,000     42,000,000
Common stock, par value (in usd per share)   $ 0.0001     $ 0.0001 $ 0.0001     $ 0.0001     $ 0.0001
Temporary equity, shares authorized (in shares)                       110,000
Temporary equity, par or stated value (in usd per share)                       $ 0.0001
Temporary equity, liquidation preference (in usd per share)                       $ 1,000
Common stock, shares, issued (in shares)   18,700,000     18,700,000 18,700,000     19,100,000     19,800,000
Stock repurchased during period (in shares) 263,158 76,000 442,000 459,000 977,000 3,900,000            
Average price paid per share (in usd per share) $ 95.00 $ 113.97 $ 93.67 $ 71.61 $ 84.88 $ 86.07            
Authorized stock repurchase amount             $ 650,000,000 $ 400,000,000 $ 300,000,000   $ 100,000,000  
Stock repurchased   $ 8,681,000 $ 41,358,000 $ 32,873,000 $ 82,912,000 $ 333,700,000            
Underwritten Public Offering                        
Schedule of Equity Method Investments [Line Items]                        
Number of shares issued in transaction (in shares) 1,500,000                      
Sale of stock, price per share (in usd per share) $ 95.00                      
Disputed Claims Reserve | Common Stock                        
Schedule of Equity Method Investments [Line Items]                        
Plan of reorganization, number of shares issued (in shares)   62,000     62,000 62,000       876,000   1,700,000